BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20083199)

  • 1. Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease.
    Bader Lange ML; St Clair D; Markesbery WR; Studzinski CM; Murphy MP; Butterfield DA
    Neurobiol Dis; 2010 Apr; 38(1):104-15. PubMed ID: 20083199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.
    Sultana R; Robinson RA; Di Domenico F; Abdul HM; St Clair DK; Markesbery WR; Cai J; Pierce WM; Butterfield DA
    J Proteomics; 2011 Oct; 74(11):2430-40. PubMed ID: 21726674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAD mutant PS-1 gene-targeted mice: increased A beta 42 and A beta deposition without APP overproduction.
    Flood DG; Reaume AG; Dorfman KS; Lin YG; Lang DM; Trusko SP; Savage MJ; Annaert WG; De Strooper B; Siman R; Scott RW
    Neurobiol Aging; 2002; 23(3):335-48. PubMed ID: 11959395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease.
    Mohmmad Abdul H; Butterfield DA
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):140-8. PubMed ID: 15955457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
    Bader Lange ML; Cenini G; Piroddi M; Abdul HM; Sultana R; Galli F; Memo M; Butterfield DA
    Neurobiol Dis; 2008 Mar; 29(3):456-64. PubMed ID: 18077176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability.
    Siman R; Reaume AG; Savage MJ; Trusko S; Lin YG; Scott RW; Flood DG
    J Neurosci; 2000 Dec; 20(23):8717-26. PubMed ID: 11102478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential in vivo amelioration by N-acetyl-L-cysteine of oxidative stress in brain in human double mutant APP/PS-1 knock-in mice: toward therapeutic modulation of mild cognitive impairment.
    Huang Q; Aluise CD; Joshi G; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
    J Neurosci Res; 2010 Sep; 88(12):2618-29. PubMed ID: 20648652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury.
    Sompol P; Ittarat W; Tangpong J; Chen Y; Doubinskaia I; Batinic-Haberle I; Abdul HM; Butterfield DA; St Clair DK
    Neuroscience; 2008 Apr; 153(1):120-30. PubMed ID: 18353561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease.
    Anantharaman M; Tangpong J; Keller JN; Murphy MP; Markesbery WR; Kiningham KK; St Clair DK
    Am J Pathol; 2006 May; 168(5):1608-18. PubMed ID: 16651627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age.
    Abdul HM; Sultana R; St Clair DK; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2008 Nov; 45(10):1420-5. PubMed ID: 18762245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
    Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
    Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis of brain proteins in APP/PS-1 human double mutant knock-in mice with increasing amyloid β-peptide deposition: insights into the effects of in vivo treatment with N-acetylcysteine as a potential therapeutic intervention in mild cognitive impairment and Alzheimer's disease.
    Robinson RA; Joshi G; Huang Q; Sultana R; Baker AS; Cai J; Pierce W; St Clair DK; Markesbery WR; Butterfield DA
    Proteomics; 2011 Nov; 11(21):4243-56. PubMed ID: 21954051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced retinal function in amyloid precursor protein-over-expressing transgenic mice via attenuating glutamate-N-methyl-d-aspartate receptor signaling.
    Shimazawa M; Inokuchi Y; Okuno T; Nakajima Y; Sakaguchi G; Kato A; Oku H; Sugiyama T; Kudo T; Ikeda T; Takeda M; Hara H
    J Neurochem; 2008 Oct; 107(1):279-90. PubMed ID: 18691390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression.
    Saito T; Matsuba Y; Yamazaki N; Hashimoto S; Saido TC
    J Neurosci; 2016 Sep; 36(38):9933-6. PubMed ID: 27656030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease.
    Emre C; Do KV; Jun B; Hjorth E; Alcalde SG; Kautzmann MI; Gordon WC; Nilsson P; Bazan NG; Schultzberg M
    Acta Neuropathol Commun; 2021 Jun; 9(1):116. PubMed ID: 34187579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short-term Western diet on cerebral oxidative stress and diabetes related factors in APP x PS1 knock-in mice.
    Studzinski CM; Li F; Bruce-Keller AJ; Fernandez-Kim SO; Zhang L; Weidner AM; Markesbery WR; Murphy MP; Keller JN
    J Neurochem; 2009 Feb; 108(4):860-6. PubMed ID: 19046405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice.
    Poon HF; Joshi G; Sultana R; Farr SA; Banks WA; Morley JE; Calabrese V; Butterfield DA
    Brain Res; 2004 Aug; 1018(1):86-96. PubMed ID: 15262209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.